Duke-Harvard-MIT Anticancer Drug Development Scholars Workshop

for early-career drug development investigators and fellows

The Duke-Harvard-MIT Anticancer Drug Development Workshop is an advanced clinical development workshop discussing the specific strategies leading to successful development pathways for new anticancer agents. The program will feature faculty speakers from FDA, Duke and the Harvard/MIT Center for Regulatory Science representing the full spectrum of anticancer drug development processes as well as regulatory science activities and will include interactive, moderated discussions. The workshop is targeted towards early-career drug development investigators and fellows, but anyone with limited knowledge of regulatory science will benefit.

The FDA defines regulatory science as the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of all FDA-regulated products. Within this guidance regulatory science will require many elements of translational medicine including innovation in measurement, trials focused on evidence generation and analysis of policies and their impact.

Scholarships covering one night’s accommodation at the Le Méridien Cambridge-MIT Hotel will be provided to academic investigators traveling from outside the Boston area. Contact mary.ruemker@duke.edu for more information.

Industry: $1,000

No charge to attend for academic investigators.


Full refund if notified via email to mary.ruemker@duke.edu by September 15. $500 refunded for notification by September 30. No refunds after this date.